Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Skin and Connective Tissue Diseases
|
Brands: Please see report, Please see report, Please see report, Please see report, Please see report |
MAH holders: Please see report, Please see report, Please see report, Please see report, Please see report |
Assessment: |
Active substance: MOMETAZONE |
ATC code: D07A C13
|
Document link:
P01970.pdf
|
Document date: 2013-10-04
|
Study number: P01970 |
EudraCT number:
|
Scope of study: CLINICAL |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
-
|
-
|